Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference
BRISBANE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq:VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced that the Company’s management team will participate in the 44th Annual TD Cowen Health Care Conference, which is taking place from March 4th to 6th at the Marriott Copley Place in Boston, MA.